Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats
Benoît Forget, Mihail Guranda, Islam Gamaleddin, et al.
Psychopharmacology (2016) Vol. 233, Iss. 10, pp. 1823-1828
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Yann Chye, Erynn Christensen, Nadia Solowij, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 119
Addiction‐related neuroadaptations following chronic nicotine exposure
Lauren Wills, Paul J. Kenny
Journal of Neurochemistry (2021) Vol. 157, Iss. 5, pp. 1652-1673
Open Access | Times Cited: 42
The Role of Nuclear Hormone Receptors in Cannabinoid Function
Marco Pistis, Saoirse E. O’Sullivan
Advances in pharmacology (2017), pp. 291-328
Closed Access | Times Cited: 53
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation
Cristina Aparecida Jark Stern, Cristiane Ribeiro de Carvalho, Leandro J. Bertoglio, et al.
Neuroscience (2017) Vol. 370, pp. 62-80
Closed Access | Times Cited: 48
The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and Their Associated Neural Mechanisms
Mark D. Namba, Seven E. Tomek, M. Foster Olive, et al.
Frontiers in Behavioral Neuroscience (2018) Vol. 12
Open Access | Times Cited: 44
URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy
Da‐Peng Wang, Qi Lin, Shao‐Hua Su, et al.
Neuroscience (2016) Vol. 344, pp. 293-304
Closed Access | Times Cited: 39
Pooled analysis of three randomized, double‐blind, placebo controlled trials with rimonabant for smoking cessation
Jason D. Robinson, Paul M. Cinciripini, Maher Karam‐Hage, et al.
Addiction Biology (2017) Vol. 23, Iss. 1, pp. 291-303
Open Access | Times Cited: 38
CB 1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal
Rocío Saravia, África Flores, Ainhoa Plaza‐Zabala, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 7, pp. 625-634
Open Access | Times Cited: 27
Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice
Wei Xu, Hong‐Chun Li, Liang Wang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
Heath D. Schmidt, Laura E. Rupprecht, Nii Addy
Complex Psychiatry (2018) Vol. 4, Iss. 4, pp. 169-189
Open Access | Times Cited: 25
FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence
Wei Zhang, Huan Liu, Xiao‐Dong Deng, et al.
Annals of Human Genetics (2019) Vol. 84, Iss. 3, pp. 259-270
Closed Access | Times Cited: 19
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors
Amélie Simonnet, Erica Zamberletti, Martine Cador, et al.
Neuropharmacology (2016) Vol. 113, pp. 252-259
Closed Access | Times Cited: 15
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models
Lauren C. Smith, Olivier George
Neuropharmacology (2020) Vol. 178, pp. 108225-108225
Open Access | Times Cited: 14
Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulation
Kevin Butler, Bernard Le Foll
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 9, pp. 1065-1080
Open Access | Times Cited: 12
Choosing the right drug: status and future of endocannabinoid research for the prevention of drug-seeking reinstatement
Miguel Á. Luján, Joseph F. Cheer, Miriam Melis
Current Opinion in Pharmacology (2020) Vol. 56, pp. 29-38
Closed Access | Times Cited: 12
The FAAH inhibitor URB597 reduces cocaine intake during conditioned punishment and mitigates cocaine seeking during withdrawal
Laia Alegre-Zurano, Alba García-Baos, Adriana Castro‐Zavala, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115194-115194
Open Access | Times Cited: 3
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment
Nikki Bozinoff, Bernard Le Foll
Expert Review of Respiratory Medicine (2018) Vol. 12, Iss. 9, pp. 793-804
Closed Access | Times Cited: 9
On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence
Karen Jaqueline Paredes-Ruiz, Karla Chavira-Ramos, Mario Orozco‐Morales, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 2072-2097
Closed Access | Times Cited: 7
Loren Parsons' contribution to addiction neurobiology
Maria Antonietta De Luca, Matthew W. Buczynski, G. Di Chiara
Addiction Biology (2018) Vol. 23, Iss. 6, pp. 1207-1222
Closed Access | Times Cited: 7
Significant association of nicotine reinforcement and cue reactivity: a translational study in humans and rats
Kevin Butler, Benoît Forget, Stephen J. Heishman, et al.
Behavioural Pharmacology (2021) Vol. 32, Iss. 2&3, pp. 212-219
Open Access | Times Cited: 6
Role of anandamide in nicotine addiction
Bernard Le Foll
Elsevier eBooks (2024), pp. 369-385
Closed Access
From Stigma to Therapy: The Evolution of Psychiatry in Substance Use Disorders
Claudia Sagheddu, Giuseppe Virdis, Miriam Melis
(2024), pp. 719-726
Closed Access
Phyto, Synthetic, and Endogenous Cannabinoids as Theoretical Possibilities of Therapeutic Molecules for the Treatment of Addictions
Virna Margarita Martín Giménez, Walter Manucha
(2024), pp. 205-209
Closed Access
Cannabinoid-based Pharmacology for the Management of Substance Use Disorders
Miguel Á. Luján, Younghoon Kim, Linlin Zhang, et al.
Current topics in behavioral neurosciences (2024)
Closed Access
Page 1 - Next Page

Scroll to top